Closed US markets are closed. They open at 14:30 UK time tomorrow.
| Share | Price | Today |
|---|---|---|
| FANG Diamondback Energy | $203.95 | up +4.27% |
| NOC Northrop Grumman | $519.86 | up +4.05% |
| FMC FMC | $5.84 | up +3.83% |
| TRGP Targa Resources | $292.44 | up +3.50% |
| EQT EQT | $54.28 | up +3.49% |
| Share | Price | Today |
|---|---|---|
| MRNA Moderna | $211.54 | down −10.55% |
| SMCI Super Micro Computer | $31.70 | down −9.66% |
| CTRA Coterra Energy | $32.56 | down −8.62% |
| DDOG Datadog | $244.87 | down −8.03% |
| STX Seagate Technology Holdings | $637.10 | down −7.77% |
Tomorrow
Share tips
How share tips workMRNAHealthcare & Pharma
Moderna (NASDAQ: MRNA) is a US biotechnology company that develops messenger RNA (mRNA) medicines. Its revenue still comes almost entirely from COVID-19 vaccines…
Updated 18 Oct 2026
GILDHealthcare & Pharma
Gilead Sciences (NASDAQ: GILD) is a US biopharmaceutical company built around HIV medicines, led by Biktarvy for treatment and the Descovy and Yeztugo…
Updated 18 Oct 2026
BMYHealthcare & Pharma
Bristol Myers Squibb (NYSE: BMY) is a US biopharmaceutical company focused on oncology, haematology, immunology, cardiovascular disease and neuroscience. It…
Updated 17 Oct 2026
ABBVHealthcare & Pharma
AbbVie (NYSE: ABBV) is a US biopharmaceutical group whose sales are led by the immunology drugs Skyrizi and Rinvoq, a fast-growing neuroscience franchise (Vraylar…
Updated 17 Oct 2026
IG: Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading spread bets and CFDs with IG. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
Sponsored. 76% of retail CFD accounts lose money. Your capital is at risk. ChartsView receives compensation when you open an account with one of these brokers.
300+ indicators, Expert Advisor signals, backtesting and XENITH real-time data
Sponsored. ChartsView may receive compensation if you sign up through these links.
A short summary of each new report, the earnings to watch and the UK and US data on the calendar. No analyst opinions, no spam. Unsubscribe any time.
A free account keeps your portfolio, watchlist and paper trades in one place, lets you post in the forum and share tips, and gets you the weekly email on Mondays.